Mabpharm Ltd. held its Annual General Meeting on June 18, 2025. The proposals on the agenda included granting a general mandate to the directors to issue, allot, and deal with additional shares of the company, which was approved. Another proposal to extend this general mandate by the aggregate number of shares repurchased by the company was also approved. All proposed resolutions were passed as ordinary resolutions at the meeting.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Mabpharm Ltd. published the original content used to generate this news brief on June 18, 2025, and is solely responsible for the information contained therein.